HELE Quote, Financials, Valuation and Earnings

European Wax Center has a net margin of 3.59% compared to Helen Of Troy's net margin of 2.67%. Helen Of Troy's return on equity of 9.04% beat European Wax Center's return on equity of 9.59%.

Helen Of Troy has a consensus price target of $92.00, signalling upside risk potential of 56.28%. On the other hand European Wax Center has an analysts' consensus of -- which suggests that it could grow by 27.3%. Given that Helen Of Troy has higher upside potential than European Wax Center, analysts believe Helen Of Troy is more attractive than European Wax Center.

Helen Of Troy has a beta of 0.898, which suggesting that the stock is 10.229% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. European Wax Center pays out 31.9% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Helen Of Troy quarterly revenues are $474.2M, which are larger than European Wax Center quarterly revenues of $55.4M. Helen Of Troy's net income of $17M is higher than European Wax Center's net income of $1.5M. Notably, Helen Of Troy's price-to-earnings ratio is 9.86x while European Wax Center's PE ratio is 28.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.72x versus 1.41x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

Hims & Hers Health has a net margin of 3.59% compared to Helen Of Troy's net margin of 18.82%. Helen Of Troy's return on equity of 9.04% beat Hims & Hers Health's return on equity of 27.83%.

Helen Of Troy has a consensus price target of $92.00, signalling upside risk potential of 56.28%. On the other hand Hims & Hers Health has an analysts' consensus of $25.21 which suggests that it could fall by -5.33%. Given that Helen Of Troy has higher upside potential than Hims & Hers Health, analysts believe Helen Of Troy is more attractive than Hims & Hers Health.

Helen Of Troy has a beta of 0.898, which suggesting that the stock is 10.229% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.309, suggesting its more volatile than the S&P 500 by 30.866%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $474.2M, which are larger than Hims & Hers Health quarterly revenues of $401.6M. Helen Of Troy's net income of $17M is lower than Hims & Hers Health's net income of $75.6M. Notably, Helen Of Troy's price-to-earnings ratio is 9.86x while Hims & Hers Health's PE ratio is 60.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.72x versus 4.88x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 3.59% compared to Helen Of Troy's net margin of -23.21%. Helen Of Troy's return on equity of 9.04% beat The Beauty Health's return on equity of -41.24%.

Helen Of Troy has a consensus price target of $92.00, signalling upside risk potential of 56.28%. On the other hand The Beauty Health has an analysts' consensus of -- which suggests that it could grow by 4.04%. Given that Helen Of Troy has higher upside potential than The Beauty Health, analysts believe Helen Of Troy is more attractive than The Beauty Health.

Helen Of Troy has a beta of 0.898, which suggesting that the stock is 10.229% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $474.2M, which are larger than The Beauty Health quarterly revenues of $78.8M. Helen Of Troy's net income of $17M is higher than The Beauty Health's net income of -$18.3M. Notably, Helen Of Troy's price-to-earnings ratio is 9.86x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.72x versus 0.64x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast PLC has a net margin of 3.59% compared to Helen Of Troy's net margin of --. Helen Of Troy's return on equity of 9.04% beat Waldencast PLC's return on equity of -9.22%.

Helen Of Troy has a consensus price target of $92.00, signalling upside risk potential of 56.28%. On the other hand Waldencast PLC has an analysts' consensus of $5.76 which suggests that it could grow by 67.93%. Given that Waldencast PLC has higher upside potential than Helen Of Troy, analysts believe Waldencast PLC is more attractive than Helen Of Troy.

Helen Of Troy has a beta of 0.898, which suggesting that the stock is 10.229% less volatile than S&P 500. In comparison Waldencast PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. Waldencast PLC pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $474.2M, which are larger than Waldencast PLC quarterly revenues of --. Helen Of Troy's net income of $17M is higher than Waldencast PLC's net income of --. Notably, Helen Of Troy's price-to-earnings ratio is 9.86x while Waldencast PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.72x versus 1.45x for Waldencast PLC. Usually stocks with elevated PS ratios are considered overvalued.